Novel fungicidal benzylsulfanyl-phenylguanidines

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 12, 2011, Pages 3686-3692

  Thevissen, Karin ^a   Pellens, Klaartje ^a   De Brucker, Katrijn ^a   François, Isabelle E J A ^a   Chow, Kwok K ^a   Meert, Els M K ^a   Meert, Wim ^a   Van Minnebruggen, Geert ^b   Borgers, Marcel ^b,c   Vroome, Valérie ^b   Levin, Jeremy ^a   De Vos, Dirk ^a   Maes, Louis ^d   Cos, Paul ^d   Cammue, Bruno P A ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Barrier Therapeutics nv   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Benzylsulfanyl phenylguanidines; Biofilm; Candida albicans; Fungicidal

Indexed keywords

6 (BENZYLSULFANYL)PYRIDIN 3 YLGUANIDINIUM DINITRATE; 6 (UNDECYLSULFANYL)PYRIDIN 3 YLGUANIDINIUM DINITRATE; BENZYLSULFANYLPHENYLGUANIDINE; FLUCONAZOLE; FUNGICIDE; GUANIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SYNTHESIS; FUNGICIDAL ACTIVITY; NONHUMAN; SURVIVAL RATE;

ANIMALS; ANTIFUNGAL AGENTS; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; GUANIDINES; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; SULFIDES;

CAENORHABDITIS ELEGANS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79957857277     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.04.075     Document Type: Article

References (28)

1. Espinel-Ingroff, A. Rev. Iberoam. Micol. 2009, 26, 15.
2. Ramage, G.; Mowat, E.; Jones, B.; Williams, C.; Lopez-Ribot, J. Crit. Rev. Microbiol. 2009, 35, 340.
3. Kojic, E. M.; Darouiche, R. O. Clin. Microbiol. Rev. 2004, 17, 255.
4. Costerton, J. W.; Marrie, T. J.; Cheng, K. J. In Phenomena of Bacterial Adhesion; Savage, D. C., Fletcher, M., Eds.; Plenum Press: New York, 1985; pp 3-43.
5. Adam, B.; Baillie, G. S.; Douglas, L. J. J. Med. Microbiol. 2002, 51, 344.
6. Mathew, B. P.; Nath, M. ChemMedChem 2009, 4, 310.
7. François, I. E.; Thevissen, K.; Pellens, K.; Meert, E. M.; Heeres, J.; Freyne, E.; Coesemans, E.; Viellevoye, M.; Deroose, F.; Martinez Gonzalez, S.; Pastor, J.; Corens, D.; Meerpoel, L.; Borgers, M.; Ausma, J.; Dispersyn, G. D.; Cammue, B. P. ChemMedChem 2009, 4, 1714.
8. Bink, A.; Govaert, G.; François, I. E.; Pellens, K.; Meerpoel, L.; Borgers, M.; Van Minnebruggen, G.; Vroome, V.; Cammue, B. P.; Thevissen, K. FEMS Yeast Res. 2010, 10, 812.
9. Borelli, C.; Schaller, M.; Niewerth, M.; Nocker, K.; Baasner, B.; Berg, D.; Tiemann, R.; Tietjen, K.; Fugmann, B.; Lang-Fugmann, S.; Korting, H. C. Chemotherapy 2008, 54, 245.
10. Pálat, K.; Braunerová G.; Miletïn, M.; Buchta, V. Chem. Pap. 2007, 61, 507.
11. Breger, J.; Fuchs, B. B.; Aperis, G.; Moy, T. I.; Ausubel, F. M.; Mylonakis, E. PLoS Pathog. 2007, 3, e18.
12. 2O containing 0.1% of/HCOOH. The used detection method is UV detection at 254 nm.
13. 13C NMR (300 MHz, DMSO): δ 150.30, 141.31, 134.80, 130.48, 129.09, 128.42, 127.76, 126.89, 120.97, 119.11, 49.76, 49.67, 33.50, 30.1, 23.30, 23.07.
14. Fonzi, W. A.; Irwin, M. Y. Genetics 1993, 134, 717.
15. Kaur, R.; Ma, B.; Cormack, B. P. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 7628.
16. 5 CFU/ml) and incubated for 2 h with different concentrations of the compounds. Cells were washed, plated on YPD (1% yeast extract, 2% peptone, 2% glucose) and after incubation, CFUs (Colony forming units) were determined. MFC, defined as the minimal concentration of the compound resulting in less than 0.1% survival of the yeast culture, was determined for both yeast species, relative to the DMSO control.
17. Graybill, J. R.; Burgess, D. S.; Hardin, T. C. Eur. J. Clin. Microbiol. Infect. Dis. 1997, 16, 42.
18. Thevissen, K.; Hillaert, U.; Meert, E. M.; Chow, K. K.; Cammue, B. P.; Van Calenbergh, S.; François, I. E. Bioorg. Med. Chem. Lett. 2008, 18, 3728.
19. Thevissen, K.; Marchand, A.; Chaltin, P.; Meert, E. M.; Cammue, B. P. Curr. Med. Chem. 2009, 16, 2205.
20. 5 CFU/ml) and incubated for 2 h with different concentrations of the compounds. After the incubation period, cells were washed, plated on TSB and CFUs were determined. Afterwards, MBC (Minimal bactericidal concentration), defined as the minimal concentration resulting in less than 0.1% survival of the bacterial culture, relative to the DMSO control treatment, was determined.
21. Peeters, E.; Nelis, H. J.; Coenye, T. J. Microbiol. Methods 2008, 72, 157.
22. -1 ampicillin) after which the colony forming units (CFUs) were determined.
23. -1 kanamycin). For toxicity testing, 40 to 50 worms were suspended in 1 mLM9 buffer in each well of 24-well microtiter plates, in the presence or absence (DMSO control) of the fungicidal compounds 665, 666, 667 and 684 (50 μM). Survival of the worms was monitored daily. The percentage survival of the worms in the presence or absence of antifungal compounds was calculated each day relative to the survival at day 0.
24. 11,28 Worms were collected and washed with M9 buffer. Survival of the worms in absence (DMSO control) or presence of compounds 665, 666, 667 and 684 (60 μM) was monitored daily. The percentage survival of the worms in presence or absence of antifungal compounds was calculated relative to the survival at day 0.
25. Tampakakis, E.; Okoli, I.; Mylonakis, E. Nat. Protocols 2008, 3, 1925.
26. Andes, D. R.; Diekema, D. J.; Pfaller, M. A.; Marchillo, K.; Bohrmueller, J. Antimicrob. Agents Chemother. 2008, 10, 3497.
27. Andes, D.; Diekema, D. J.; Pfaller, M. A.; Prince, R. A.; Marchillo, K.; Ashbeck, J.; Hou, J. Antimicrob. Agents Chemother. 2008, 52, 539.
28. Okoli, I.; Coleman, J. J.; Tampakakis, E.; An, W. F.; Holson, E.; Wagner, F.; Conery, A. L.; Larkins-Ford, J.; Wu, G.; Stern, A.; Ausubel, F. M.; Mylonakis, E. PLoS One 2009, 4, e7025.